Literature DB >> 2054305

Identification of anti-HIV-1 antibodies in bloodstains of various ages.

G Pappalardo1, G Sermasi, M C Re, G Furlini, S Pelotti, F Malferrari.   

Abstract

The persistence of anti-HIV-1 antibodies in bloodstains has been studied by ELISA and Western Blot (WB) analysis. The immunoblot technique was found to be specific and more sensitive and the antibodies could be detected in 0.7 mg of bloodstains for up to 6 months. The authors emphasize the importance of such an investigation on non-genetic markers in individual diagnosis for forensic purposes.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2054305     DOI： 10.1007/bf01626032

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN： 0937-9827            Impact factor:   2.686


  5 in total

1.  [Antibodies to human immunodeficiency virus (HIV) in medico-legal autopsy material].

Authors:  P Geertinger; B Kringsholm; B O Lindhardt; H Sørensen; P Theilade; P Wantzin
Journal:  Ugeskr Laeger       Date:  1988-04-11

2.  Antibody profiling of bloodstains.

Authors:  L A King; D J Werrett; P H Whitehead
Journal:  Forensic Sci       Date:  1976 Sep-Oct

3.  [The detection of HIV antibodies in blood stains].

Authors:  A Stiebler; S Neifer; U Sucker; U Bienzle; V Schneider
Journal:  Z Rechtsmed       Date:  1989

4.  The occurrence of HIV antibodies in drug addicts autopsied at the University Institute of Forensic Medicine in Copenhagen in 1987.

Authors:  B Kringsholm; P Theilade; P Geertinger
Journal:  Forensic Sci Int       Date:  1989-06       Impact factor: 2.395

5.  Detection of antibodies to human immunodeficiency virus (HIV) in eluates from whole blood impregnated filter paper discs.

Authors:  B O Lindhardt; I C Bygbjerg; K Ulrich; H D Petersen; I Lausen; B Frederiksen
Journal:  J Virol Methods       Date:  1987-10       Impact factor: 2.014
  5 in total
  1 in total

1.  Diagnosis of HIV infection from bloodstains by PCR. A further marker for identification.

Authors:  R Giorgetti; M Rassu; A Tagliabracci; E Franchin; G Palù; S D Ferrara
Journal:  Int J Legal Med       Date:  1995       Impact factor: 2.686
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.